Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-12-10 10:04:12 |
Versijas komentārs | |
Teksts |
Third Quarter 2014 Investor Conference Webinar
On December 9 AS „Olainfarm” organized its third quarter 2014
Investor Conference Online Webinar. During the webinar the member
of the management board of AS „Olainfarm” Salvis Lapiņš analyzed
the financial results of third quarter 2014 and informed about the
company’s future activities, paying extra attention to CAPEX
investment program.
During the webinar Salvis
Lapiņš said that considering current AS „Olainfarm” stock price
tendencies, company’s Board has decided not to pursue the stock
split idea, which was discussed earlier, for the time being.
Answering to the question
of 2015 financial forecasts, Salvis Lapiņš noted that certain
growth can be expected next year, but more detailed information is
yet unknown.
The recorded “Olainfarm” webinar is available online:
http://ej.uz/OLF_3Q_2014,
and the presentation, demonstrated during the webinar, can be found
in the previously published AS “Olainfarm” announcement:
https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=636447&messageId=790219.
Olainfarm thanks all participants, who joined the webinar, and
encourages everybody to follow company’s announcements to get
information on the next webinar!
JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia
Information prepared
by: Salvis Lapins |
Pielikumi |
|